Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation
Maud D’Aveni, Anne Béatrice Notarantonio, Allan Bertrand, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 25

Showing 25 citing articles:

Effects of Glucose Metabolism, Lipid Metabolism, and Glutamine Metabolism on Tumor Microenvironment and Clinical Implications
Longfei Zhu, Xuanyu Zhu, Yanyou Wu
Biomolecules (2022) Vol. 12, Iss. 4, pp. 580-580
Open Access | Times Cited: 90
Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?
Chiel van Geffen, Astrid Deißler, Markus Quante, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse
Viviane Gournay, Nicolas Vallet, Vivien Peux, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1305-1321
Open Access | Times Cited: 39
The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative
Nathan Karin
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 56
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Shunjie Yu, Xiaotong Ren, Lijuan Li
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation
Anne-Béatrice Notarantonio, Allan Bertrand, Romain Piucco, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
Vaishali Bhardwaj, Stephen M. Ansell
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 12
The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
Christos Demosthenous, Ioanna Sakellari, Vassiliki Douka, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 10, pp. 2050-2050
Open Access | Times Cited: 27
Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases
Jilu Zhang, Alan W. Hodges, Shu‐Hsia Chen, et al.
Cellular Immunology (2021) Vol. 362, pp. 104300-104300
Open Access | Times Cited: 24
Contemporary understanding of myeloid-derived suppressor cells in the acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) tumor microenvironment
Abdulrahman Alhajahjeh, Maximilian Stahl, Tae Kyoung Kim, et al.
Expert Review of Anticancer Therapy (2025), pp. 1-22
Closed Access
Tolerance After Hematopoietic Stem Cell Transplantation
Gérard Socié, David Michonneau, Pavan Reddy
Elsevier eBooks (2025)
Closed Access
Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial
Forrest L. Baker, Jessica Stokes, Megan J. Cracchiolo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Uncovering the multifaceted roles played by neutrophils in allogeneic hematopoietic stem cell transplantation
Cristina Tecchio, Marco A. Cassatella
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 4, pp. 905-918
Open Access | Times Cited: 18
Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
Iosif Papafragkos, Efrosyni Markaki, Christina Kalpadakis, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3462-3462
Open Access | Times Cited: 12
The adaptor protein TRAF3 is an immune checkpoint that inhibits myeloid-derived suppressor cell expansion
Sining Zhu, Almin Lalani, Juan Jin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation
Maite Álvarez, Antonio Pierini, Federico Simonetta, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 7
Assessment of monocytic‐myeloid‐derived suppressive cells (M‐MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients
Pierre Péterlin, Marie C. Béné, Maxime Jullien, et al.
eJHaem (2023) Vol. 4, Iss. 4, pp. 1089-1095
Open Access | Times Cited: 2
Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies
Alejandro Olivares-Hernández, Luis Figuero-Pérez, Eduardo Terán-Brage, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1919-1919
Open Access | Times Cited: 5
Three distinct tolerogenic CD14+ myeloid cell types to actively manage autoimmune disease: Opportunities and challenges
Glenn F. van Wigcheren, Daphne Roelofs, Carl G. Figdor, et al.
Journal of Autoimmunity (2021) Vol. 120, pp. 102645-102645
Open Access | Times Cited: 5
Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD
Claire Gérard, Marine Thébault, Baptiste Lamarthée, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
Eric Chang-Yi Lin, Shuoh-Wen Chen, Luen-Kui Chen, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 2
CD14 + HLADR - blood values in patients after alloHSCT are highly predictive of survival and infectious complications
Emilia Jaskuła, Janusz Lange, Mariola Sędzimirska, et al.
Transplant Immunology (2021) Vol. 65, pp. 101370-101370
Closed Access | Times Cited: 1
A research on the influence of G-CSF mobilization on donor's peripheral blood MDSCs and its relationship with patient prognosis
Rong Wang, Man Chen, Minjing Fu, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110998-110998
Open Access
Immunology of Hematopoietic Stem Cell Transplantation
Maud D’Aveni, Anne Béatrice Notarantonio, Cécile Pochon, et al.
Elsevier eBooks (2022), pp. 571-585
Closed Access
Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease
Maud D’Aveni, Anne-Béatrice Notarantonio, Viviane A. Agbogan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access
Page 1

Scroll to top